Age Group | Proportion of False-Positive Examination Findings |
Specificities (95% CIs) |
||||||
---|---|---|---|---|---|---|---|---|
Pang et al2 (4 mm) | Gire et al3 (2.5 mm) | 2 SDs | 3 SDs | Pang et al2 (4 mm) | Gire et al3 (2.5 mm) | 2 SDs | 3 SDs | |
Younger than 12 mo | 0/21 | 1/21 | 1/21 | 1/21 | 1.0 (0.85–1.0) | 0.95 (0.77–0.99) | 0.95 (0.77–0.99) | 0.95 (0.77–0.99) |
12–24 mo | 0/19 | 12/19 | 1/19 | 0/19 | 1.0 (0.83–1.0) | 0.37 (0.19–0.59) | 0.94 (0.73–0.99) | 1.0 (0.83–1.0) |
2–4 yr | 0/17 | 14/17 | 1/17 | 0/17 | 1.0 (0.82–1.0) | 0.18 (0.06–0.41) | 0.94 (0.73–0.99) | 1.0 (0.82–1.0) |
5–8 yr | 0/19 | 13/19 | 0/19 | 0/19 | 1.0 (0.83–1.0) | 0.32 (0.15–0.54) | 1.0 (0.83–1.0) | 1.0 (0.83–1.0) |
9–12 yr | 0/16 | 3/16 | 0/16 | 0/16 | 1.0 (0.81–1.0) | 0.81 (0.57–0.93) | 1.0 (0.72–0.99) | 1.0 (0.81–1.0) |
13–17 yr | 0/19 | 0/19 | 2/19 | 0/19 | 1.0 (0.83–1.0) | 1.0 (0.83–1.0) | 0.89 (0.69–0.97) | 1.0 (0.83–1.0) |
Older than 17 yr | 0/13 | 0/13 | 1/13 | 0/13 | 1.0 (0.67–1.0) | 1.0 (0.67–1.0) | 0.92 (0.67–0.99) | 1.0 (0.67–1.0) |